参考文献/References:
[1]陈利华,黄学全. 盆腔复发性肿瘤的125I内放射治疗进展. 现代生物医学进展,2009,9(19): 3791-3793.
[2]王俊杰,冉维强,姜玉良,等.超声引导放射性125I粒子植入治疗头颈部复发或转移癌.中国微创外科杂志,2007,7(2):120-122.
[3]李孟达.宫颈复发癌的诊断和治疗.实用妇产科杂志,1994,10(5):242-243.
[4]Temple WJ, Saettler EB. Locally recurrent rectal cancer : role of composite resection of extensive pelvic tumors with strategies for minimizing risk of recurrence. J Surg Oncol, 2000,73(1):47-58.
[5]Moore DH, Blessing JA, McQuellon RP, et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol, 2004, 22 (15):3113-3119.
[6]Tsuda H, Hashiguchi Y, Nishimura S, et al. Phase III study of irinotecan(CPT11) plus nedaplatin (254S) with recombinant human granulocyte colonystimulating factor support in patients with advanced or recurrent cervical cancer. Br J Cancer, 2004, 91 (6):1032-1037.
[7]范卫君,张亮,张福君,等. CT导向下125I粒子植入治疗复发性盆腔恶性肿瘤.中国微创外科杂志,2007, 7 (2):127-129.
[8]Nag S, Ellis RJ, Merrick GS, et al. American Brachytherapy Society recommendations for reporting morbidity after prostate brachytherapy. Int J Radiat Oncol Biol Phys, 2002,54(2):462-470.
[9]Sharma SK, Forgione H, Isaacs JH. Iodine125 interstitial implants as salvage therapy for recurrent gynecologic malignancies. Cancer,1991,67 (10): 2467-2471.
[10]李长江,黄金华,范卫君,等.CT导向下125I 粒子植入联合髂内动脉化疗灌注治疗盆腔复发肿瘤.介入放射学杂志,2005,14(6):610-612.
[11]武峰,张蓓,周玲,等. MSCT引导下植入125 I 粒子治疗盆腔恶性肿瘤22例分析.西部医学,2010,22(3):506-511.